These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1713629)

  • 1. Molecular analysis of a human liver mitochondrial ornithine transcarbamylase deficiency.
    Berrez JM; Bardot O; Thiard MC; Alvarez F; Latruffe N
    J Inherit Metab Dis; 1991; 14(1):29-36. PubMed ID: 1713629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ornithine transcarbamylase deficiency: a case with a truncated enzyme precursor and a case with undetectable mRNA activity.
    Kodama H; Ohtake A; Mori M; Okabe I; Tatibana M; Kamoshita S
    J Inherit Metab Dis; 1986; 9(2):175-85. PubMed ID: 3091923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary ornithine transcarbamylase deficiency. A case report and electron microscopic study.
    Aida S; Ogata T; Kamota T; Nakamura N
    Acta Pathol Jpn; 1989 Jul; 39(7):451-6. PubMed ID: 2678891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients.
    Nishiyori A; Yoshino M; Kato H; Matsuura T; Hoshide R; Matsuda I; Kuno T; Miyazaki S; Hirose S; Kuromaru R; Mori M
    Hum Genet; 1997 Feb; 99(2):171-6. PubMed ID: 9048915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly basic N-terminal extension of the mitochondrial matrix enzyme ornithine transcarbamylase from rat liver.
    McIntyre P; Graf L; Mercer J; Peterson G; Hudson P; Hoogenraad N
    FEBS Lett; 1984 Nov; 177(1):41-6. PubMed ID: 6548714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency.
    Engel K; Nuoffer JM; Mühlhausen C; Klaus V; Largiadèr CR; Tsiakas K; Santer R; Wermuth B; Häberle J
    Mol Genet Metab; 2008 Jul; 94(3):292-7. PubMed ID: 18440262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of ornithine transcarbamylase deficiency lacking enzyme protein.
    Saheki T; Imamura Y; Inoue I; Miura S; Mori M; Ohtake A; Tatibana M; Katsumata N; Ohno T
    J Inherit Metab Dis; 1984; 7(1):2-8. PubMed ID: 6429436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency.
    Carstens RP; Fenton WA; Rosenberg LR
    Am J Hum Genet; 1991 Jun; 48(6):1105-14. PubMed ID: 2035531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
    Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
    Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level expression of a mitochondrial enzyme, ornithine transcarbamylase from rat liver, in a baculovirus expression system.
    Lithgow T; Ristevski S; Höj P; Hoogenraad N
    DNA Cell Biol; 1991; 10(6):443-9. PubMed ID: 2069719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP; Bendiks M; Mori M; Kominami E; Robinson MB; Ye X; Wilson JM
    Mol Med; 1999 Apr; 5(4):244-53. PubMed ID: 10448647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH.
    Shchelochkov OA; Li FY; Geraghty MT; Gallagher RC; Van Hove JL; Lichter-Konecki U; Fernhoff PM; Copeland S; Reimschisel T; Cederbaum S; Lee B; Chinault AC; Wong LJ
    Mol Genet Metab; 2009 Mar; 96(3):97-105. PubMed ID: 19138872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene for OTC: characterisation and linkage to Duchenne muscular dystrophy.
    Davies KE; Briand P; Ionasescu V; Ionasescu G; Williamson R; Brown C; Cavard C; Cathelineau L
    Nucleic Acids Res; 1985 Jan; 13(1):155-65. PubMed ID: 3839070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency.
    García-Pérez MA; Climent C; Briones P; Vilaseca MA; Rodés M; Rubio V
    J Inherit Metab Dis; 1997 Nov; 20(6):769-77. PubMed ID: 9427144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamyl phosphate synthetase and ornithine transcarbamylase activities in enzyme-deficient human liver measured by radiochromatography and correlated with outcome.
    Tuchman M; Tsai MY; Holzknecht RA; Brusilow SW
    Pediatr Res; 1989 Jul; 26(1):77-82. PubMed ID: 2771513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ornithine transcarbamylase deficiency in spf and spf-ash mice: genes, mRNAs and mRNA precursors.
    Ohtake A; Takayanagi M; Yamamoto S; Nakajima H; Mori M
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1064-70. PubMed ID: 3039990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compared expression levels of ornithine transcarbamylase and carbamylphosphate synthetase in liver and small intestine of normal and mutant mice.
    Dubois N; Cavard C; Chasse JF; Kamoun P; Briand P
    Biochim Biophys Acta; 1988 Sep; 950(3):321-8. PubMed ID: 3167057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
    Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
    Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoenzymatic studies of ornithine transcarbamylase (OTC) in liver of patients with OTC deficiency by enzyme linked immunosorbent assay (ELISA).
    Oyanagi K; Tsubakihara K; Itakura Y; Nagao M; Takayanagi N; Tsuchiyama A; Nakao T; Inoue I; Saheki T
    Tohoku J Exp Med; 1987 May; 152(1):15-21. PubMed ID: 3617058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells.
    Lee JT; Nussbaum RL
    J Clin Invest; 1989 Dec; 84(6):1762-6. PubMed ID: 2556444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.